Back to Parexel Insights

Terry’s cancer journey: Triumphant testimony to the power of precision oncology

By Gwyn Bebb, M.D., BM, BCh, Ph.D., Senior Vice President, Global Therapeutic Area Head – Oncology

For over 20 years, precision oncology has advanced cancer care by tailoring treatments to individual needs, improving outcomes, and empowering patients on their cancer journey. Bev Hope, Marketing Strategy Director interviews Dr. Gwyn Bebb, Senior Vice President and Global Therapeutic Head of Oncology, and his former patient Terry Morey, a stage four non-small cell lung cancer survivor. They share their unique journey battling Terry’s NSCLC through the lens of precision oncology. Terry’s experience with various treatments, including ALK inhibitors, sheds light on the transformative potential of precision oncology for more cancer patients. 

Their story highlights the importance of expanding patient access to clinical trials and biomarker testing. It is a story about science, the human spirit, resilience, and relentless pursuit to transform lives. Terry’s cancer journey is a beacon of hope and a testament to the power of precision oncology to revolutionize cancer care and improve outcomes for more cancer patients and their families today and in future generations.

Contributing Experts

Gwyn Bebb, M.D., BM, BCh, Ph.D.

Senior Vice President, Global Therapeutic Area Head – Oncology

Read bio

Learn what's possible now

Stay current with novel thinking and actionable insights from our experts.

Start a conversation

Learn more about how Parexel is advancing precision oncology

The vision of precision oncology—to treat each patient with the exact right medicine—is within reach yet still remote. We will move closer to the long-term vision by solving practical short-term problems and prioritizing innovation. At Parexel, we navigate multi-omics profiling, biomarkers, dose optimization, clinical trial site selection, companion diagnostics, regulatory strategy, and commercialization one challenge at a time while staying focused on improving the patient journey, our North Star. 

Our oncology-focused patient advocates, scientists, statisticians, and former regulators are proud to partner with sponsors to advance precision oncology.

Learn More